IDH1 Mutation Induces HIF-1α and Confers Angiogenic Properties in Chondrosarcoma JJ012 Cells
Open Access
- 14 February 2022
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2022, 1-11
Abstract
Chondrosarcoma is a group of primary bone cancers that arise from transformed cells of chondrocytic lineage. Tumor recurrence and metastasis are devastating for patients with chondrosarcoma since there are no effective treatment options. IDH mutations occur in over 50 of tumors from patients with conventional or dedifferentiated chondrosarcomas and represent an attractive target for therapy. However, their role in the pathogenesis of chondrosarcoma remains largely unknown. In this study, we sought to determine the association of IDH mutation and HIF-1α in chondrosarcoma. We used the chondrosarcoma JJ012 cell line and its derived CRISPR/Cas9 mutant IDH1 (IDH1mut) knockout (KO) cells. RNA-Seq data analysis revealed downregulation of several HIF-1α target genes upon loss of IDH1mut. This was associated with reduced HIF-1α levels in the IDH1mut KO cells and tumors. Loss of IDH1mut also attenuated the expression of angiogenic markers in tumor tissues and abrogated the angiogenic capacity of JJ012 cells. Moreover, we observed that exogenous expression of HIF-1α significantly promoted anchorage-independent colony-formation by IDH1mut KO cells. These results suggest IDH1 mutation confers angiogenic and tumorigenic properties of JJ012 cells by inducing HIF-1α. Thus, the HIF pathway represents a promising candidate for combinatorial regimens to target IDH1 mutated chondrosarcomas.Keywords
Funding Information
- Shandong First Medical University (2019RC003, 81871895, 1 P30 240139-01)
- Young Taishan Scholars and Academic Promotion Program (2019RC003, 81871895, 1 P30 240139-01)
- National Natural Science Foundation of China (2019RC003, 81871895, 1 P30 240139-01)
- National Cancer Institute (2019RC003, 81871895, 1 P30 240139-01)
- University of Miami (2019RC003, 81871895, 1 P30 240139-01)
This publication has 42 references indexed in Scilit:
- D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane functionGenes & Development, 2012
- The mechanisms of IDH mutations in tumorigenesisCell Research, 2012
- Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activationNature, 2012
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionNature Reviews Cancer, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Activation of tumor cell integrin α v β 3 controls angiogenesis and metastatic growth in the brainProceedings of the National Academy of Sciences, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Integrins in angiogenesis and lymphangiogenesisNature Reviews Cancer, 2008
- Anoikis mechanismsCurrent Opinion in Cell Biology, 2001